While many people think attaining healthy weight loss is as easy as eating a balanced diet and engaging in regular physical ...
The FDA has approved a new drug called zolbetuximab designed to attack a novel target that’s in a type of stomach cancer.
Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.
Six months after scoring FDA approval for hemophilia B gene therapy Beqvez, Pfizer has earned a nod from the U.S. regulator for another of its products in the indication. On Friday, the FDA signed ...
announced today that the U.S. Food and Drug Administration (FDA) has approved HYMPAVZIâ„¢ (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in ...
The U.S. Food and Drug Administration (FDA) has approved flurpiridaz F-18 (Flyrcado; GE Healthcare), a first-of-its-kind positron emission tomography (PET) imaging agent, for use in adult patients ...
Ten years after first collecting an FDA approval, it’s time for version number two. Exact Sciences has received an agency green light for Cologuard Plus, the next generation of its mainstay ...
The approval came days before the FDA’s expected deadline and makes this ... fetal toxicity are also possible. 1. U.S. Food and Drug Administration approves perioperative treatment of ...
The Food and Drug Administration (FDA) last week approved Bristol Myers Squibb’s antipsychotic drug Cobenfy (xanomeline and trospium chloride), the first schizophrenia treatment with an entirely new ...
The Food and Drug Administration (FDA) has approved Flyrcado â„¢ (flurpiridaz F 18), a cyclotron-produced radioactive diagnostic agent, for positron emission tomography (PET) myocardial perfusion ...
The U.S. Food and Drug Administration (FDA) has approved flurpiridaz F-18 (Flyrcado; GE Healthcare), a first-of-its-kind positron emission tomography (PET) imaging agent, for use in adult patients ...
The U.S. Food and Drug Administration has approved Zevra Therapeutics' Miplyffa ... Urologic and Reproductive Medicine in the FDA Center for Drug Evaluation and Research, said in a statement.